The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More
The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More
Racura Oncology recently raised AU$34.3 (US$24.31) million to fund its RC220 clinical programmes in acute myeloid leukaemia (AML), epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer, and anthracycline cardioprotection in solid tumour patients. Diana Turner speaks to Dr Peter Smith, Executive Chair of Racura, about… Read More
DDW Editor Reece Armstrong speaks to David Crean, Chief Business Officer of biopharmaceutical company MediciNova, about recent turmoil within the FDA and what the pharma sector should expect from the agency going forward. It’s been a volatile couple of years for the United States. President Trump’s second term… Read More
Diana Turner catches up with Seth Lederman, Co-Founder, CEO and Chairman of Tonix Pharmaceuticals, about the company’s new preventative monoclonal antibody therapy for Lyme disease. DT: For anyone who hasn’t come across the disease before, what is Lyme disease and how is it contracted? SL: Lyme disease… Read More
Megan Thomas spoke to Leon Moore, Head of Global Brand Strategy & Marketing at Astellas, about how the company’s new Asset Maximization Teams are fostering collaboration and improving outcomes. MT: Astellas recently implemented a new structure, for its research, development and commercial teams to get innovative medicines to patients,… Read More
DDW’s Diana Turner speaks to Catherine Whittington, Associate Professor in the Department of Biomedical Engineering at WPI about her current work and the research that drives her. DT: Can you tell us what you do and what you’re working on at the moment? CW: I teach classes in the biomedical… Read More
In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More
In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More
This is the latest episode of the free DDW narrated podcast, titled “Strategies and challenges in therapeutic development and lab practice”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The inner workings of antibiotics”, “Targeting advances in immunotherapies”, and… Read More
Diana Turner caught up with Graham Hatfull, Eberly Family Professor of Biotechnology at the University of Pittsburgh, following his election to the Fellowship of the Royal Society. DT: Can you tell us what you do and what you’re working on at the moment? GH: My lab studies bacteriophages (phages),… Read More
NurExone Biologics has been named a finalist in Falling Walls Venture 2025, a global platform that showcases the world’s most promising science-based start-ups. With plans to move into clinical trials next year with an exosome therapy for spinal cord injuries, Diana Turner caught up Dr Lior Shaltiel, CEO… Read More
This is the latest episode of the free DDW narrated podcast, titled “UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr… Read More
To celebrate Research Appreciation Day 2025 on 5 July, DDW’s Diana Turner has collated the best career advice from our Meet the Researcher interviewees over the last year. Enjoy what you do “It is important to enjoy what you do, as it takes a lot of your time and… Read More
This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Advances in neuroscience drug discovery”, “Putting human data at the centre of… Read More
DDW’s Megan Thomas examines the work of Dr Duncan McHale, Chief Medical Officer at Persica Pharmaceuticals. MT: Can you tell us what you do and what you’re working on at the moment? DM: In 2017, I founded an early drug development consultancy called Weatherden with Houman Ashrafian and Emma… Read More
